Life Sciences

LIFE SCIENCES BY SIMON SILVER Department of Microbiology & Immunology University of Illinois Chicago, IlL " The availability of a range of human growth factors made on a factory scale from, recombinant DNA technology, will radically advance treatment for wounds and other skin trauma. There is also a lot to learn about basic cell biology from the study of these proteins. P. ten Dijke, K.K. Iwata, “Growth factors for wound healing,” BioTechnology, 7, 793-8, August 1989. (Oncogene

Written bySimon Silver
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

BY SIMON SILVER
Department of Microbiology
& Immunology
University of Illinois
Chicago, IlL

" The availability of a range of human growth factors made on a factory scale from, recombinant DNA technology, will radically advance treatment for wounds and other skin trauma. There is also a lot to learn about basic cell biology from the study of these proteins.

P. ten Dijke, K.K. Iwata, “Growth factors for wound healing,” BioTechnology, 7, 793-8, August 1989. (Oncogene Science Inc., Manhasset, N.Y.) " Lyme disease, a “disease of the year” for campers and suburbanites, is caused by a spirochete, which (uniquely for bacteria) has a linear chromosome.

M.S. Ferdows, A.G. Barbour, “Megabase-sized linear DNA in the bacterium Borrelia burgdorferi, the Lyme disease agent,” PNAS, 86, 5969-73, August 1989. (University of Texas Health Science Center, San Antonio)

" Review journals such as Trends in Biochemical Sciences have become increasingly useful in rapidly changing areas. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies